help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaponnier, C.
Right arrow Articles by Gabbiani, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaponnier, C.
Right arrow Articles by Gabbiani, G.

American Journal of Pathology, Vol 134, 597-603, Copyright © 1989 by American Society for Investigative Pathology


REGULAR ARTICLES

Gelsolin modulation in epithelial and stromal cells of mammary carcinoma

C Chaponnier and G Gabbiani
Department of Pathology, University of Geneva, Switzerland.

Gelsolin, a Ca2+-sensitive protein present in many mammalian cells, regulates actin filament length by multiple mechanisms. In tumor cells, increased amounts of F-actin without change in its total amount have been observed, suggesting a modification in the organisation of this protein. The authors have localized gelsolin, total actin, alpha-smooth muscle actin, and prekeratin in frozen sections of normal human breast and infiltrating duct carcinomas by immunohistochemistry. A positive staining for gelsolin was observed in normal epithelial and myoepithelial cells but not in stromal fibroblasts. In contrast, no staining for gelsolin was detectable in carcinomatous cells, with the exception of remaining myoepithelial cells; myofibroblasts of the stromal reaction displayed an intense positive reaction. The absence of gelsolin staining in the epithelial cells of breast carcinoma may reflect their dedifferentiation or proliferative and invasive activities. The appearance of gelsolin in stromal cells raises the question as to what is its function in this situation. The immunohistochemical detection of gelsolin may be a useful adjunct to the study of mammary gland epithelium malignant transformation.


This article has been cited by other articles:


Home page
DiabetesHome page
B. Yermen, A. Tomas, and P. A. Halban
Pro-Survival Role of Gelsolin in Mouse {beta}-Cells
Diabetes, January 1, 2007; 56(1): 80 - 87.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Clement, B. Hinz, V. Dugina, G. Gabbiani, and C. Chaponnier
The N-terminal Ac-EEED sequence plays a role in {alpha}-smooth-muscle actin incorporation into stress fibers
J. Cell Sci., April 1, 2005; 118(7): 1395 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. B. Glaser, J. Li, M. E. Aakre, D. W. Morgan, G. Sheppard, K. D. Stewart, J. Pollock, P. Lee, C. Z. O'Connor, S. N. Anderson, et al.
Transforming Growth Factor {beta} Mimetics: Discovery of 7-[4-(4-Cyanophenyl)phenoxy]-Heptanohydroxamic Acid, a Biaryl Hydroxamate Inhibitor of Histone Deacetylase
Mol. Cancer Ther., August 1, 2002; 1(10): 759 - 768.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. D. Thor, S. M. Edgerton, S. Liu, D. H. Moore II, and D. J. Kwiatkowski
Gelsolin as a Negative Prognostic Factor and Effector of Motility in erbB-2-positive Epidermal Growth Factor Receptor-positive Breast Cancers
Clin. Cancer Res., August 1, 2001; 7(8): 2415 - 2424.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-W. Han, S. H. Ahn, S. H. Park, S. Y. Wang, G.-U. Bae, D.-W. Seo, H.-K. Kwon, S. Hong, H. Y. Lee, Y.-W. Lee, et al.
Apicidin, a Histone Deacetylase Inhibitor, Inhibits Proliferation of Tumor Cells via Induction of p21WAF1/Cip1 and Gelsolin
Cancer Res., November 1, 2000; 60(21): 6068 - 6074.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
M. Chellaiah, N. Kizer, M. Silva, U. Alvarez, D. Kwiatkowski, and K. A. Hruska
Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength
J. Cell Biol., February 21, 2000; 148(4): 665 - 678.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Chew, J. Parente, X Chen, C Chaponnier, and R. Cameron
The LIM and SH3 domain-containing protein, lasp-1, may link the cAMP signaling pathway with dynamic membrane restructuring activities in ion transporting epithelia
J. Cell Sci., January 6, 2000; 113(11): 2035 - 2045.
[Abstract] [PDF]


Home page
Cancer Res.Home page
P. A. Folger, W. J. Berg, Z. DeJesus, Y. Fong, and J. D. Pardee
A Mammalian Severin Replaces Gelsolin in Transformed Epithelial Cells
Cancer Res., October 1, 1999; 59(20): 5349 - 5355.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. A. JANMEY
The Cytoskeleton and Cell Signaling: Component Localization and Mechanical Coupling
Physiol Rev, July 1, 1998; 78(3): 763 - 781.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. D. Arora and C. A.G. McCulloch
Dependence of Fibroblast Migration on Actin Severing Activity of Gelsolin
J. Biol. Chem., August 23, 1996; 271(34): 20516 - 20523.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C. Vasconcellos, P. Allen, M. Wohl, J. Drazen, P. Janmey, and T. Stossel
Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin
Science, February 18, 1994; 263(5149): 969 - 971.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Society for Investigative Pathology.